Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9450482rdf:typepubmed:Citationlld:pubmed
pubmed-article:9450482lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:9450482lifeskim:mentionsumls-concept:C0949852lld:lifeskim
pubmed-article:9450482lifeskim:mentionsumls-concept:C1572543lld:lifeskim
pubmed-article:9450482lifeskim:mentionsumls-concept:C1510707lld:lifeskim
pubmed-article:9450482lifeskim:mentionsumls-concept:C1326912lld:lifeskim
pubmed-article:9450482lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9450482lifeskim:mentionsumls-concept:C0452440lld:lifeskim
pubmed-article:9450482lifeskim:mentionsumls-concept:C1515358lld:lifeskim
pubmed-article:9450482lifeskim:mentionsumls-concept:C0047964lld:lifeskim
pubmed-article:9450482pubmed:issue12lld:pubmed
pubmed-article:9450482pubmed:dateCreated1998-2-11lld:pubmed
pubmed-article:9450482pubmed:abstractTextThe present study investigated the inhibitory activity against lung tumorigenesis by a group of characteristic black tea polyphenols, theaflavins. In a short-term study, female A/J mice were treated with a single dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK; 103 mg/kg b.w., i.p.) on day 0, and 0.1 and 0.3% theaflavins were administered as the sole source of drinking fluid starting 24 h after NNK treatment. The proliferation index of the lung tissues was measured by the incorporation of bromodeoxyuridine (BrdU) immunohistochemically. The highest NNK-induced proliferation rate of bronchiolar cells, observed on day 5, was significantly decreased by 0.3% theaflavins (proliferation index, 1.51 +/- 0.08 versus 2.35 +/- 0.16). In a long-term lung tumorigenesis study, pulmonary adenomas were observed in 100% (30/30) of the mice at week 16 after NNK treatment. Administration of theaflavins (0.1%) as the sole source of drinking fluid, starting 2 days after the NNK treatment until the termination of the experiment, significantly reduced the tumor multiplicity and volume by 23% (8.5 +/- 0.6 versus 6.5 +/- 0.6 tumors/mouse) and 34% (0.08 versus 0.05 mm3 per tumor), respectively. The proliferation index in lung adenomas was also significantly inhibited by theaflavins. The present work demonstrates the inhibitory action of theaflavins against NNK-induced pulmonary hyperproliferation and tumorigenesis.lld:pubmed
pubmed-article:9450482pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:languageenglld:pubmed
pubmed-article:9450482pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:citationSubsetIMlld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9450482pubmed:statusMEDLINElld:pubmed
pubmed-article:9450482pubmed:monthDeclld:pubmed
pubmed-article:9450482pubmed:issn0143-3334lld:pubmed
pubmed-article:9450482pubmed:authorpubmed-author:KimSSlld:pubmed
pubmed-article:9450482pubmed:authorpubmed-author:LimRRlld:pubmed
pubmed-article:9450482pubmed:authorpubmed-author:YangC SCSlld:pubmed
pubmed-article:9450482pubmed:authorpubmed-author:LiaoJJlld:pubmed
pubmed-article:9450482pubmed:authorpubmed-author:YangG YGYlld:pubmed
pubmed-article:9450482pubmed:authorpubmed-author:DingWWlld:pubmed
pubmed-article:9450482pubmed:authorpubmed-author:SerilD NDNlld:pubmed
pubmed-article:9450482pubmed:authorpubmed-author:BondocFFlld:pubmed
pubmed-article:9450482pubmed:issnTypePrintlld:pubmed
pubmed-article:9450482pubmed:volume18lld:pubmed
pubmed-article:9450482pubmed:ownerNLMlld:pubmed
pubmed-article:9450482pubmed:authorsCompleteYlld:pubmed
pubmed-article:9450482pubmed:pagination2361-5lld:pubmed
pubmed-article:9450482pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:meshHeadingpubmed-meshheading:9450482-...lld:pubmed
pubmed-article:9450482pubmed:year1997lld:pubmed
pubmed-article:9450482pubmed:articleTitleBlack tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice.lld:pubmed
pubmed-article:9450482pubmed:affiliationLaboratory for Cancer Research, College of Pharmacy, Rutgers University, Piscataway, NJ 08855-0789, USA.lld:pubmed
pubmed-article:9450482pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9450482pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9450482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9450482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9450482lld:pubmed